Marico ne Vietnam mein kiya entry! Skinetiq ko ₹350 Cr mein kharid kar boom karne ka plan

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Marico ne Vietnam mein kiya entry! Skinetiq ko ₹350 Cr mein kharid kar boom karne ka plan
Overview

Marico ne Vietnam mein ek badi deal ki hai. Unhone wahaan ki direct-to-consumer skincare company Skinetiq mein **75%** stake kharid li hai, lagbhag **₹350 Crore** mein. Isse unko wahaan ka badhta hua beauty market pakadne mein help milegi.

Marico ka Vietnam mein Dastak: Skinetiq ko ₹350 Crore mein kharida!

Dekho bhaiyo aur behno, Marico ne Vietnam mein ek mast move kiya hai! Company ne wahaan ki skincare brand Skinetiq Joint Stock Company mein 75% hissa kharid liya hai, deal value hai lagbhag ₹350 Crore. Yeh deal Skinetiq ko uski projected 2025 revenue ka 2.3x Price-to-Sales multiple de rahi hai, jo ki kafi premium valuation hai. Marico ka plan hai Vietnam ke booming beauty market mein apna premium presence mazboot karna.

Kya hai Skinetiq ka Magic?

Skinietiq, jo ki 2020 mein shuru hui thi, ek digital-first company hai. Ye apne 'Candid' brand ke through science-backed skincare products bechti hai aur Vietnam mein luxury brand 'Murad' ki exclusive distributor bhi hai. Company ne apni kamai ko ₹45 Crore (CY2023) se badha kar ₹152 Crore (CY2025 projected) tak pahunchane ka andaza lagaya hai, aur unke EBITDA margins bhi mid-twenties mein maintain hain. Marico ko isse apna international D2C business badhane mein help milegi.

Vietnam ka Beauty Market: E-commerce ka Zor!

Vietnam ka beauty aur personal care market 2025 tak $2.74 Billion tak pahunchne ka umeed hai. Aur iska 50% se zyada consumption toh e-commerce se ho raha hai! Isi trend ko dekhte hue Marico ne yeh deal ki hai. Marico khud bhi ek badi company hai, jiska market cap lagbhag ₹98,000 Crore hai aur P/E ratio 57x ke aas paas chal raha hai. Unki international operations already group revenue ka 25% contribute karti hain.

Valuation ka Gamble aur Risks

Lekin bhai, har deal mein kuch risks toh hote hain. Yahaan 2.3x P/S multiple par Skinetiq ko kharidna thoda mehnga lag sakta hai agar growth expectations poori nahi hui. Online competition bahut tight hai, aur social commerce par depend karna bhi challenging ho sakta hai. Vietnam market ko samajhna aur execution sahi se karna Marico ke liye ek bada test hoga. Plus, company sirf do founders dwara 2020 mein shuru hui thi, toh long-term leadership continuity ka risk bhi hai.

Future Outlook: ₹20,000 Crore Ka Target

Marico ke liye yeh deal unke 2030 tak ₹20,000 Crore revenue ke ambitious target ko paane ka ek important step hai. Ab investors yahi dekhenge ki Marico kaise Skinetiq ko integrate karti hai, uske digital model ka fayda uthati hai, aur Vietnam jaise emerging market mein profitable growth lati hai. Deal ka premium valuation balance karna hi asal challenge rahega.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.